These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8451622)

  • 1. Experience of a laboratory service for drug screening in urine.
    Simpson D; Greenwood J; Jarvie DR; Moore FM
    Scott Med J; 1993 Feb; 38(1):20-6. PubMed ID: 8451622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug screening and confirmation by GC-MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories.
    Lu NT; Taylor BG
    Forensic Sci Int; 2006 Mar; 157(2-3):106-16. PubMed ID: 15899564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of drug use by participants in the Western Australian methadone program, 1984-1991.
    Swensen G; Ilett KF; Dusci LJ; Hackett LP; Ong RT; Quigley AJ; Lenton S; Saker R; Caporn J
    Med J Aust; 1993 Sep; 159(6):373-6. PubMed ID: 8104312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of immunoassays in screening for opiates, cannabinoids and amphetamines in post-mortem blood.
    Hino Y; Ojanperä I; Rasanen I; Vuori E
    Forensic Sci Int; 2003 Jan; 131(2-3):148-55. PubMed ID: 12590054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance abuse testing of urine by GC/MS in scanning mode evaluated by proficiency studies, TLC/GC, and EMIT.
    Gibb RP; Cockerham H; Goldfogel GA; Lawson GM; Raisys VA
    J Forensic Sci; 1993 Jan; 38(1):124-33. PubMed ID: 8381160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of DRI enzyme immunoassays for drugs-of-abuse screening on the Cobas Mira.
    Broussard LA; Hanson L
    Clin Lab Sci; 1997; 10(2):83-6. PubMed ID: 10166356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical issues associated with urine testing of substances of abuse.
    Eskridge KD; Guthrie SK
    Pharmacotherapy; 1997; 17(3):497-510. PubMed ID: 9165553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of several immunoassays used in drugs of abuse screening: Assessment against gold standard methods and calculation of measurement uncertainty.
    Mina A
    J Pharmacol Toxicol Methods; 2020; 101():106649. PubMed ID: 31730939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the MTP immunoassay with EMIT in blood screening for drugs].
    Käferstein H; Sticht G
    Arch Kriminol; 1998; 202(5-6):165-72. PubMed ID: 10023491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of psychoactive substances in truck drivers in the Nord-Pas-de-Calais region (France).
    Labat L; Fontaine B; Delzenne C; Doublet A; Marek MC; Tellier D; Tonneau M; Lhermitte M; Frimat P
    Forensic Sci Int; 2008 Jan; 174(2-3):90-4. PubMed ID: 17418990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for drugs of abuse. I: Opiates, amphetamines and cocaine.
    Braithwaite RA; Jarvie DR; Minty PS; Simpson D; Widdop B
    Ann Clin Biochem; 1995 Mar; 32 ( Pt 2)():123-53. PubMed ID: 7785941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicological screening in trauma.
    Carrigan TD; Field H; Illingworth RN; Gaffney P; Hamer DW
    J Accid Emerg Med; 2000 Jan; 17(1):33-7. PubMed ID: 10658989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
    Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
    Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance evaluation of four on-site drug-testing devices for detection of drugs of abuse in urine.
    Peace MR; Tarnai LD; Poklis A
    J Anal Toxicol; 2000 Oct; 24(7):589-94. PubMed ID: 11043664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Bionike one-step tests for the detection of drugs of abuse in urine.
    Brown ER; Jarvie DR; Simpson D
    Ann Clin Biochem; 1997 Jan; 34 ( Pt 1)():74-80. PubMed ID: 9022891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug screening during pregnancy: Urine dip cups measure up.
    Kroska EB; Meller EW; Doyle R; Coker JL; Knight BT; Ray-Griffith SL; Nembhard WN; Stowe ZN
    Drug Alcohol Depend; 2019 Nov; 204():107461. PubMed ID: 31521952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid confirmation of enzyme multiplied immunoassay technique (EMIT) cocaine positive urine samples by capillary gas-liquid chromatography/nitrogen phosphorus detection (GLC/NPD).
    Verebey K; DePace A
    J Forensic Sci; 1989 Jan; 34(1):46-52. PubMed ID: 2645381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of meconium, maternal urine and neonatal urine for detection of maternal drug use during pregnancy.
    Wingert WE; Feldman MS; Kim MH; Noble L; Hand I; Yoon JJ
    J Forensic Sci; 1994 Jan; 39(1):150-8. PubMed ID: 8113697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between drug screening by immunoassay and ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry in post-mortem urine.
    Sundström M; Pelander A; Ojanperä I
    Drug Test Anal; 2015 May; 7(5):420-7. PubMed ID: 24953563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of six methods for the detection of drugs of abuse in urine.
    Simpson D; Jarvie DR; Heyworth R
    Ann Clin Biochem; 1989 Mar; 26 ( Pt 2)():172-81. PubMed ID: 2729861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.